Upstream Medical Technologies
Seacliff · Founded 2015
About Upstream Medical Technologies
Upstream Medical Technologies is a medical diagnostics company specializing in cardiovascular disease testing. It develops a cardio endocrine bio-markers designed for accurate diagnosis of heart disease and associated complications, enabling doctors to detect and treat heart diseases without causing much harm to the patient. Its patented technology is based on specialist protein peptides. Upstream's pipeline of tests enables earlier diagnosis for improved patient recovery. The diagnostics company was founded by Chris Pemberton in Seacliff, Otago in 2015.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.8M
- Last round: Series Unknown (May 2023)
- Website: http://www.upstreamdx.com/
- Phone: +64 9 892 6999
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/upstream-medical-technologies-106079 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.